MBChi, MSc, MD, FRCP, FRCPath
Specialises in
Virtual consultations:
I am a Senior Consultant Haematologist who has held the position of Consultant Haematologist since 2005, following extensive experience in both adult and paediatric clinical and laboratory haematology.
I possess comprehensive expertise in diagnosing and treating a wide array of benign and malignant blood disorders, including leukaemias, lymphomas, and myelomas.
I spearheaded a five-year modernisation program for the thrombosis service at Mersey and Lancashire Teaching Hospitals NHS Trust and served as the Principal Investigator for the first national trial examining the use of the new direct oral anticoagulant, Rivaroxaban, in treating cancer-induced thrombosis.
I have a robust background in internal medicine, an excellent foundation for analysing patient symptoms, leading to a broader perspective in diagnosis and management.
I have contributed extensively to research, including clinical research papers, case reports, and textbook chapters, and take pride in delivering exceptional clinical and patient care.
Some of the principal treatments carried out by Dr Maged Gharib at Spire include:
Other treatments
COVID-19 testing or antibody tests are not available as a standalone service at Spire Manchester Hospital.
British Society for Haematology
European Haematology Association
Royal College of Pathologists
Royal College of Physicians
UK Higher Education Academy (Advance HE)